Last update :
08/05/2024
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
Valistab
Valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter
Analgesic   Sufentanil citrate  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers
Fentatienil Italy
Sudolfen Colombia
Sufenta Austria, Belgium, Canada, Chile, Denmark, Finland, France, Germany, Iceland, Iran, Luxembourg, Malaysia, Netherlands, Norway, Poland, Portugal, Republic of South Africa, Saudi Arabia, Sweden, Switzerland, Tunisia, Turkey, United States of America
Zuftil Mexico
Stability of mixtures   Injection   Stability of mixtures : Sufentanil citrate     
Container Solvent Concentration Compound Temperature Storage Duration of stability References
Glass None 7 mg/ml
Injection   Sufentanil citrate   
Injection   Palonosetron hydrochloride 25 µg/ml
25°C
4 Hour
Light 2196
Level of evidence A+
Glass None 0.0062 mg/ml
Injection   Sufentanil citrate   
Injection   Palonosetron hydrochloride 25 µg/ml
25°C
4 Hour
Light 2196
Level of evidence A+
Polyvinyl chloride Not specified 0,02 mg/ml
Injection   Sufentanil citrate   
Injection   Bupivacaine hydrochloride 3 mg/ml
26°C
10 Day
Not specified 1491
Level of evidence D
Polyvinyl chloride Not specified 0,02 mg/ml
Injection   Sufentanil citrate   
Injection   Bupivacaine hydrochloride 3 mg/ml
37°C
10 Day
Not specified 1491
Level of evidence D
Polyvinyl chloride Not specified 0,02 mg/ml
Injection   Sufentanil citrate   
Injection   Bupivacaine hydrochloride 3 mg/ml
4°C
10 Day
Protect from light 1491
Level of evidence D
Polyvinyl chloride Sodium chloride 0,9% 0,001 mg/ml
Injection   Sufentanil citrate   
Injection   Levobupivacaine hydrochloride 1,25 mg/ml
-30°C
120 Day
Protect from light 1938
Level of evidence A
Polyvinyl chloride Sodium chloride 0,9% 0,012 mg/ml
Injection   Sufentanil citrate   
Injection   Bupivacaine hydrochloride 0,04 mg/ml
25°C
43 Day
Not specified 1909
Polyvinyl chloride Sodium chloride 0,9% 0,005 mg/ml
Injection   Sufentanil citrate   
Injection   Bupivacaine hydrochloride 2 mg/ml
32°C
3 Day
Not specified 510
Polyvinyl chloride Sodium chloride 0,9% 0,005 mg/ml
Injection   Sufentanil citrate   
Injection   Bupivacaine hydrochloride 2 mg/ml
4°C
30 Day
Protect from light 510
Polyvinyl chloride Sodium chloride 0,9% 0,001 mg/ml
Injection   Sufentanil citrate   
Injection   Levobupivacaine hydrochloride 1,25 mg/ml
4°C
58 Day
Protect from light 1962
Level of evidence C
Polyvinyl chloride Sodium chloride 0,9% 0,001 mg/ml
Injection   Sufentanil citrate   
Injection   Levobupivacaine hydrochloride 1,25 mg/ml
4°C
70 Day
Protect from light 1938
Level of evidence A
Polyvinyl chloride Sodium chloride 0,9% 0,012 mg/ml
Injection   Sufentanil citrate   
Injection   Bupivacaine hydrochloride 0,04 mg/ml
4°C
43 Day
Not specified 1909
Polyvinyl chloride Sodium chloride 0,9% 0,001 mg/ml
Injection   Sufentanil citrate   
Injection   Levobupivacaine hydrochloride 1,25 mg/ml
4°C
58 Day
Not specified 1908
Level of evidence A
Polyvinyl chloride Sodium chloride 0,9% 0,00075 mg/ml
Injection   Sufentanil citrate   
Injection   Ropivacain hydrochloride 1,2 mg/ml
4°C
180 Day
Not specified 4522
Level of evidence B
Polypropylene Sodium chloride 0,9% 0,0005 mg/ml
Injection   Sufentanil citrate   
Injection   Bupivacaine hydrochloride 0,00125 mg/ml
2-8°C
28 Day
Protect from light 2319
Level of evidence B
Polypropylene Sodium chloride 0,9% 0,03 mg/ml
Injection   Sufentanil citrate   
Injection   Clonidine hydrochloride 0,015 mg/ml
Injection   Midazolam hydrochloride 3,6 mg/ml
25°C
7 Day
Light 3705
Level of evidence D
Polypropylene Sodium chloride 0,9% 0,03 mg/ml
Injection   Sufentanil citrate   
Injection   Lormetazepam 0,12 mg/ml
25°C
7 Day
Light 3705
Level of evidence D
Polypropylene Sodium chloride 0,9% 0,03 mg/ml
Injection   Sufentanil citrate   
Injection   Midazolam hydrochloride 3,6 mg/ml
25°C
7 Day
Light 3705
Level of evidence D
Polypropylene Sodium chloride 0,9% 0,03 mg/ml
Injection   Sufentanil citrate   
Injection   Clonidine hydrochloride 0,015 mg/ml
Injection   Piritramide 1 mg/ml
Injection   Midazolam hydrochloride 3,6 mg/ml
Injection   Ketamine hydrochloride 25 mg/ml
Injection   Lormetazepam 0,12 mg/ml
25°C
8 Hour
Light 3705
Level of evidence D
Polypropylene Sodium chloride 0,9% 0,0033 mg/ml
Injection   Sufentanil citrate   
Injection   Propofol 6,7 mg/ml
Injection   Midazolam hydrochloride 1,2 mg/ml
25°C
24 Hour
Light 4011
Level of evidence C+
Polypropylene Sodium chloride 0,9% 0,0033 mg/ml
Injection   Sufentanil citrate   
Injection   Propofol 6,7 mg/ml
Injection   Piritramide 0,33 mg/ml
25°C
24 Hour
Light 4011
Level of evidence C+
Polypropylene Sodium chloride 0,9% 0,0075 mg/ml
Injection   Sufentanil citrate   
Injection   Propofol 5 mg/ml
Injection   Midazolam hydrochloride 0,9 mg/ml
Injection   Lormetazepam 0,03 mg/ml
25°C
24 Hour
Light 4011
Level of evidence C+
Polypropylene Sodium chloride 0,9% 0,01 mg/ml
Injection   Sufentanil citrate   
Injection   Dexmedetomidine 6,6 µg/ml
Injection   Propofol 6,7 mg/ml
25°C
24 Hour
Light 4011
Level of evidence C+
Polypropylene Sodium chloride 0,9% 0,01 mg/ml
Injection   Sufentanil citrate   
Injection   Propofol 6,7 mg/ml
Injection   Clonidine hydrochloride 0,005 mg/ml
25°C
24 Hour
Light 4011
Level of evidence C+
Polypropylene Sodium chloride 0,9% 0,015 mg/ml
Injection   Sufentanil citrate   
Injection   Propofol 10 mg/ml
25°C
24 Hour
Light 4011
Level of evidence C+
Polypropylene Sodium chloride 0,9% 0,027 mg/ml
Injection   Sufentanil citrate   
Injection   Propofol 1,8 mg/ml
25°C
24 Hour
Light 4011
Level of evidence C+
Polypropylene Sodium chloride 0,9% 0,0027 mg/ml
Injection   Sufentanil citrate   
Injection   Propofol 18 mg/ml
25°C
24 Hour
Light 4011
Level of evidence C+
Polypropylene Sodium chloride 0,9% 0,0004 mg/ml
Injection   Sufentanil citrate   
Injection   Ropivacain hydrochloride 1 & 2 mg/ml
30°C
30 Day
Protect from light 1665
Polypropylene Sodium chloride 0,9% 0,004 mg/ml
Injection   Sufentanil citrate   
Injection   Ropivacain hydrochloride 2 mg/ml
30°C
30 Day
Protect from light 1665
Polypropylene Sodium chloride 0,9% 0,001 mg/ml
Injection   Sufentanil citrate   
Injection   Levobupivacaine hydrochloride 1,25 mg/ml
4°C
180 Day
Not specified 4522
Level of evidence B
Polypropylen Syringe Sodium chloride 0,9% 0,003 >>0,045 mg/ml
Injection   Sufentanil citrate   
Injection   Ziconotide acetate 0,2 >> 3 µg/ml
2-8°C
7 Day
Not specified 4496
Level of evidence D
Polypropylen Syringe Sodium chloride 0,9% 0,00113 mg/ml
Injection   Sufentanil citrate   
Injection   Levobupivacaine hydrochloride 1,22 mg/ml
21°C
28 Day
Protect from light 1835
Level of evidence D
Polypropylen Syringe Sodium chloride 0,9% 0,00113 mg/ml
Injection   Sufentanil citrate   
Injection   Levobupivacaine hydrochloride 1,22 mg/ml
36°C
28 Day
Protect from light 1835
Level of evidence D
Polypropylen Syringe Sodium chloride 0,9% 0,00113 mg/ml
Injection   Sufentanil citrate   
Injection   Levobupivacaine hydrochloride 1,22 mg/ml
4°C
28 Day
Protect from light 1835
Level of evidence D
Polypropylen Syringe Sodium chloride 0,9% 0,001 mg/ml
Injection   Sufentanil citrate   
Injection   Levobupivacaine hydrochloride 1,25 mg/ml
4°C
180 Day
Not specified 4522
Level of evidence B
Polypropylen Syringe Sodium chloride 0,9% 0,00075 mg/ml
Injection   Sufentanil citrate   
Injection   Ropivacain hydrochloride 1,2 mg/ml
4°C
180 Day
Not specified 4522
Level of evidence B
Not specified Sodium chloride 0,9% 1 mg/ml
Injection   Sufentanil citrate   
Injection   Ziconotide acetate 25 µg/ml
37°C
33 Day
Protect from light 2280
Level of evidence D
  Mentions Légales